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Activity of the Escherichia coli cardiolipin synthase, encoded by cls, increased about IO-fold in the stationary growth phase, while other committed- 
step enzymes in phospholipid biosynthesis rather decreased. A null cls mutant lost viability to 10M4 of the wild-type cells during the prolonged 
incubation for 5 days. Cardiolipin was most stable among membrane phospholipids during the incubation. Accordingly, cardiolipin should play 
a role in survival of the cell and E. coli employs a sophisticated way to form cardiolipin according to need even under non-growing conditions. 
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1. INTRODUCTION 
Cardiolipin (also known as diphosphatidylglycerol) is
unique among membrane phospholipids in its structure, 
having four acyl chains and two phosphate groups, and 
is known to be important for the activities of electron 
transport enzymes in eucaryotic mitochondria [ 1,2]. In 
Escherichia coli, cardiolipin is one of the major phospho- 
lipids in membranes. However, its essentiality is uncer- 
tain [3] and its specific functions, if any, have not been 
understood; the previously reported requirements for 
this lipid were almost equally satisfied by another major 
acidic phospholipid, phosphatidylglycerol (for a recent 
review, see [4]). In addition to its unclear functions, 
cardiolipin of E. coli has several curious features in its 
biosynthesis, the biological significance of which has 
not been explained: (i) it is mainly synthesized by car- 
diolipin synthase, encoded by cls [3], via condensation 
of two phosphatidylglycerol molecules [5,6], in contrast 
to the eucaryotic counterparts that more economically 
utilize one molecule each of CDP-diacylglycerol and 
phosphatidylglycerol [7,8]; (ii) its contents in mem- 
branes increase significantly in the stationary growth 
phase and under conditions where the cellular energy 
level is lowered [6,9-111; and (iii) its synthesis is en- 
hanced when phosphatidylethanolamine synthesis is im- 
paired by defects in phosphatidylserine synthase [12,13]. 
The recent development of a useful assay method for 
E. coli cardiolipin synthase [14,15] has enabled us to 
examine the synthase activity accurately for many 
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strains under various growth conditions. Here we de- 
scribe observations that explain many of the unique 
features in cardiolipin biosynthesis and suggest an im- 
portant role for this particular lipid in survival of the 
cell. 
2. MATERIALS AND METHODS 
2.1. Bacterial strains, plasmid, and culture conditions 
E. coli K-12 strains W3110 (wild type) [16], JE5513 (lpp-2) [17], 
YA5513 (JE5513 pgsA3) [18], JP5513 (JE5513 pssA1, formerly pss-1) 
[19], and SlOl (W3110 cZs::kan) [20] were described previously. In the 
last strain, the promoterless kan gene of pUC-4K [21] was inserted into 
the chromosomal cls gene to form an operon fusion [3], so that the 
kanamycin phosphotransferase activity corresponded to the transcrip- 
tional expression of the cls gene. Plasmid pCLl1 was a derivative of 
pBR322 carrying the intact cls locus [22]. Cells were grown in LB 
medium [23] at 37“C, except for strain JP5513 which was grown at 
42’C for the maximum phenotype. Ampicillin was added to the me- 
dium at 50 pg per ml when plasmid-harboring cells were cultured. 
Growth was monitored in a Klett-Summerson photometer; 1 Klett 
unit corresponded to approximately 5x lo6 cells per ml. Unless other- 
wise specified, cells were harvested for enzyme assay at Klett unit 100 
(exponential phase) or at 2 h after the cessation of turbidity increase 
(Klett unit 300, stationary phase). Viable cells were counted by plating 
diluted cultures on LB plates containing 1.5% agar. 
2.2. Assay conditions for enzymes and phospholipids 
Cardiolipin synthase was assayed by the standard method described 
previously [14,15], except that 200 PM phosphatidyl[2-3Hlglycerol 
and 0.03% Triton X-100 were used, instead of the standard 20 PM 
substrate and 0.015% Triton X-100, to minimize the possible diluting 
effect of endogenous phosphatidylglycerol. Activities of sn-glycerol-3- 
phosphate acyltransferase [24], phosphatidylserine synthase [25], and 
phosphatidylglycerophosphate synthase [26] were measured as previ- 
ously described, Kanamycin phosphotransferase was assayed using 
[r-‘*P]ATP (ICN Biomedicals, Inc., Irvine, CA) as described [27]. One 
unit of enzyme activity was defined as 1 nmol of reaction product 
formed in 1 min. Phospholipids were extracted from the cells uni- 
formly labeled with , 32P separated by two-dimensional thin-layer 
chromatography, and quantified from their radioactivity as previously 
described [28]. 
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3. RESULTS 
3.1. Growth-phase dependent cardiolipin synthase activ- 
ity 
Cardiolipin synthase activities were measured for the 
wild-type and mutant cells harvested both in the expo- 
nential and stationary growth phases (Table I). The 
specific enzyme activity in the stationary phase was 13- 
times higher than that in the exponential phase in strain 
JE5513. A phase-dependent change in cardiolipin syn- 
thase was clearly seen in a time-course xperiment with 
another wild-type strain W3110 (Fig. 1). The specific 
activity in the cells of overnight culture decreased rap- 
idly upon inoculation into a new medium and turned to 
increase gradually in the mid-exponential phase, reach- 
ing the maximum at about 5 h after the cessation of 
turbidity increase. Under these conditions, the cellular 
phosphatidylglycerol level changed from 19% of the 
total phospholipid phosphorus (exponential phase) to 
9% (stationary phase). Since this change corresponded 
to no more than 5% of the amount of radioactive sub- 
strate added in the assay mixture, possible errors, if any, 
due to the variable dilution of the substrate specific 
radioactivity were not significant. 
Table I also shows the results with mutant strains 
defective in the committed steps in the biosyntheses of 
three major phospholipids. Glycerol release was not 
detected with the membrane fraction from a null cls 
mutant, indicating that the assay method employed was 
specific to cardiolipin synthase, not measuring the sec- 
ondary minor reaction of cardiolipin formation which 
takes place even in null cls mutants [3,28]. The phase- 
dependent change of cardiolipin synthase activity was 
also seen in pssA1 and pgsA3 mutants which had a 
temperature-sensitive phosphatidylserine synthase [28] 
and a defective phosphatidylglycerophosphate synthase 
[29], respectively, suggesting that the observed change 
in cardiolipin synthase activity did not depend on the 
phospholipid composition of the membrane. The syn- 
thase activity in the exponential phase was significantly 
higher in these mutants than the wild-type strain and 
this may explain the higher contents of cardiolipin, rel- 
ative to those of phosphatidylglycerol, in pssA1 and 
Table I 
Cardiolipin synthase activities in the exponential and stationary 
growth phases 
Strain Phospholipid 
gene 
JE5513 Wild 
SlOl cls::kan 
JP5513 pssAl 
YA5513 PgsAJ 
*Below the detection limit. 
Specific activity (unitsImp protein) 
Exponential Stationary S/E 
(E) (S) 
1.6 20.9 13 
< 0.3s c 0.3* _ 
9.4 29.2 3.1 
5.3 21.1 4.0 
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Fig. 1. Growth-phase-dependent cardiolipin synthase activity in wild- 
type strain, W3110. 
pgsA3 mutants [12,29]. Hirschberg and Kennedy [5] re- 
ported an activation of cardiolipin synthesis in crude 
envelope preparations by CDP-diacylglycerol, which 
actually accumulates in these mutants [29,30], although 
CDP-diacylglycerol rather inhibits the activity of highly 
purified cardiolipin synthase preparations under our 
assay conditions [3 11. 
In contrast to cardiolipin synthase, activities of three 
other committed-step enzymes in the phospholipid bio- 
synthetic pathway did not increase but rather decreased 
in the stationary growth phase (Table II), indicating 
that cardiolipin synthase is unique in the phospholipid 
biosynthesis. 
To understand the mechanism of phase-dependent 
change of cardiolipin synthase activity, kanamycin 
phosphotransferase activities in different growth phases 
were assayed in a cls-kan operon fusion strain. The 
specific activities (units per mg protein) in strain SlOl 
harvested at Klett 120 (exponential phase), Klett 280 
(early stationary phase), and at 6 h after the cessation 
of turbidity increase (late stationary phase) were 110, 
143, and 101, respectively (averages of duplicate meas- 
urements). This suggested that the change in the tran- 
scriptional expression of the cls gene, if not at all, was 
not large enough to explain the observed changes in 
cardiolipin synthase activity. 
3.2. Cardiolipin-dependent survival of the cell 
To examine the physiological implication of cardiol- 
ipin in the stationary phase, viable cells were counted 
for prolonged cultures of strain W3 110, its isogenic null 
cls mutant SlOl, and SlOl harboring pCLl1 (Fig. 2). 
Day 1 in the figure was 2 h after the cessation of turbid- 
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INCUBATION TIME (day) 
Fig. 2. Cardiolipin-dependent survival of E. coli cells. Strains W3110 
(0) and SlOl (ckkun) (0) were incubated with shaking in LB medium 
in Monod (L-shaped) tubes at 37% SlOl harboring pCLl1 (a) was 
incubated under the same conditions, except for the addition of ampi- 
cillin in the medium. Starting at 2 h after the cessation of turbidity 
increase (day l), aliquotes were withdrawn at intervals for viable cell 
count. 
ity increase. Viable cells in 1 ml of the culture of SlOl 
at day 5 was 10e4 of that of W3 110. Under these condi- 
tions, the viability loss of SlOl/pCLl 1 was no more 
than that of W3110, indicating that the faster death of 
SlOl was due to the lack of cardiolipin synthase. Three 
repeated experiments gave essentially the same results 
(data not shown). In W3110 at day 5 under these incu- 
bation conditions, the cellular contents of phosphati- 
dylethanolamine and phosphatidylglycerol decreased to 
16% and 13% of those at day 1, respectively, whereas 
63% of cardiolipin of day 1 remained at day 5, resulting 
in a phospholipid headgroup composition of 31% 
phosphatidylethanolamine, 3% phosphatidylglycerol, 
and 57% cardiolipin. At day 5, the total phospholipid 
content in SlOl was 50% of that in W3 110. The results 
indicated that cardiolipin was more stable than other 
major phospholipids and this might be related to the 
lower surviving ability of strain SlOl. 
4. DISCUSSION 
The activity of cardiolipin synthase, but not of other 
phospholipid enzymes, has been found to increase sig- 
Table II 
Activities of phospholipid enzymes in strain W3110 in the exponential 
and stationary growth phases 
Enzyme Specific activity (units/mg protein) 
Exponential Stationary S/E 
(E) (S) 
G3P* acyltransferase 0.23 0.10 0.4 
Phosphatidylserine synthase 20.6 14.6 0.7 
PGP* synthase 12.1 6.8 0.6 
*G3P, sn-glycerol-3-phosphate; PGP, phosphatidylglycerophosphate. 
nificantly in the stationary growth phase in E. cdi cells. 
A special care has been taken to minimize the possible 
assay errors due to a phase-dependent change in the 
amount of endogenous phosphatidylglycerol, despite 
the previous suggestions that the endogenous and ex- 
ogenous phosphatidylglycerol fractions do not mix 
[6,14]. The assay method employed here is highly spe- 
cific for the E. coli cardiolipin synthase and much more 
sensitive than those described previously [14,15]. Al- 
though Tunaitis and Cronan previously reported that 
the cardiolipin synthase activity in the late stationary 
phase was about half that observed in the exponential 
phase [6], it does not necessarily comhct with the pres- 
ent result in which we showed a decrease in the synthase 
activity upon prolonged culture in the stationary phase 
(Fig. 1). 
The active increase in the synthase activity explains, 
at least partly, the well-known increase in cardiolipin 
content in the stationary phase. It is possible, however, 
that the cardiolipin-specific phosphodiesterase, the ac- 
tivity of which has been reported to depend on ATP or 
the substrate in energetized membranes [32,33], is also 
involved in the stationary-phase increase of cardiolipin. 
The actual contribution of this putative catabolic en- 
zyme in the regulation of cardiolipin content remains to 
be quantitatively examined. 
The molecular mechanism underlying the observed 
change in cardiolipin synthase activity is at present un- 
known. The transcriptional expression of the cls gene, 
as assessed by the kanamycin phosphotransferase activ- 
ity in a cl+kan operon fusion strain, did not seem to 
change much during the course of culture. Cardiolipin 
synthase activities were similar in pssAZ and pgsA3 
mutants, in which phospholipid compositions are mark- 
edly different from that of the wild-type strain, suggest- 
ing that the cardiolipin synthase activity was not regu- 
lated by the phospholipid environment. Whatever the 
mechanism is, the active increase in cardiolipin synthase 
activity appears to be physiologically significant; the cls 
null mutation, without appreciable growth phenotypes 
[3], caused a remarkably faster loss of viability under 
the present experimental conditions. Since the lag times 
necessary before the growth resumption of stationary- 
phase cells were essentially the same for strains W3110 
and S 101 (unpublished data), cardiolipin must play a 
role in survival of the cell during the non-growth period, 
possibly ensuring the minimum phospholipid content in 
the membranes and also stabilizing the membrane 
structures. 
With regard to the importance of cardiolipin in the 
stationary phase, we point out the unique nature of the 
E. coli cardiolipin synthase; its substrate is solely 
phosphatidylglycerol that amply exists in the mem- 
brane. In contrast to this and other procaryotic cardio- 
lipin synthases [4], eucaryotic counterparts catalyze the 
condensation of phosphatidylglycerol and CDP-dia- 
cylglycerol, the reaction apparently more economical to 
223 
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form cardiolipin. However, the mechanism to utilize 
only phosphatidylglycerol should be advantageous for 
procaryotic cells that have to survive in variable and 
severe environments; CDP-diacylglycerol is maintained 
at a low and definite level and its synthesis requires a 
new energy supply [4]. Accordingly, the active increase 
in cardiolipin synthesis under adverse conditions must 
be a physiologically significant regulation and E. coli 
appears to have adopted the type of enzyme that allows 
such a regulation. 
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